BeStock  
Stocks › Biotechnology › SNDX

Syndax Pharmaceuticals SNDX

US equityMarket cap rank #3319Biotechnology
$8.72 −$0.41 (-4.49%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.72 0.00%
Open$9.07
Prev close$9.13
Day range$8.69 – $9.27
Volume2.18M
Market cap$785.05M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

SNDX at a glance

Shares of Syndax Pharmaceuticals are down 4.49% at $8.72. The company is worth $785.05M, number 3319 out of 3753 on our list.

It is close to the bottom of its 52-week range ($8.41 to $25.59), 65.9% under the high. Holders are behind 50.0% over twelve months, and down 55.4% across the last three months.

On the chart it has slipped under both the 50-day ($14.22) and 200-day ($19.43) moving averages; RSI is 28, which some call oversold, and the last 30 sessions moved at roughly 117% annualized volatility.

In the quarter ended Sep 2026 the company brought in $83.30M of revenue, up 81.6% from a year earlier, and a net loss of $49.43M.

6 analysts follow the stock and the average call is "buy". The mean target, $37.67, sits 332.0% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$8.72 / $9.15
Average price today$8.88
Volume2.18MAvg (90d) 2.25M
Turnover$19.38M
Turnover rate2.69%of shares outstanding
Volume ratio0.73vs. recent average pace
Day amplitude6.35%
Market cap$785.05M
Float market cap$707.10M
Shares outstanding81.09M
EPS (TTM)-$3.29
P/B-45.65
Book value / share-$0.19
Net profit (TTM)-$296.19M
Net assets-$17.20M
30-day volatility117.2%annualized
Avg daily range (ATR)11.59%of price, 14 days
Max drawdown (1y)-66.0%-65.3% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

D
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

D
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

6 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 24.9 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability15.1
Momentum4.2
Financial health70.5
Analyst view91.1

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$37.67+332.0% vs. current price
Consensus ratingBuy6 analysts covering
Morningstar fair value$12.23Price is below fair value

Wall Street’s average 12-month target is $37.67, 332.0% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $12.23, so shares trade 28.7% below that estimate. On earnings multiple, it sits in the 66th percentile of its own five-year valuation range (pricier than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-4.5%
1 week
-7.7%
1 month
-35.7%
3 months
-55.4%
6 months
-56.3%
Year to date
-58.5%
1 year
-50.0%
Day range
$8.69$9.27
52-week range
$8.41$25.59

Technical signals

Full technicals →
Trend readStrong downtrend

1 bullish · 5 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-20.1%Bearish
Price vs 50-day average-38.7%Bearish
Price vs 200-day average-55.1%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)28.0Neutral
MACD (12,26,9)-1.64Bullish
Bollinger band position25%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How SNDX ranks on BeStock

Market value#3303 of 3734
Closeness to 52-week high#3436 of 3724
Dollar volume today#2030 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

SNDX is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on SNDX.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on SNDX

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

SNDX stock: common questions

How is Syndax Pharmaceuticals stock doing today?

$8.72 is the latest print for SNDX, a move of -4.49% against yesterday's close of $9.13. Today's low and high so far: $8.69 and $9.27.

How big is Syndax Pharmaceuticals?

Equity value comes to $785.05M at the current price. By that measure it is number 3319 of the 3753 names in our coverage.

Where does SNDX sit in its 52-week range?

The year's floor is $8.41 and the ceiling $25.59. Shares are 65.9% away from that ceiling.

Does SNDX send cash back through a dividend?

Our data shows no dividend paid by Syndax Pharmaceuticals over the trailing twelve months.

Do Wall Street analysts like SNDX?

Of 6 analysts, 83% say buy, 17% hold and 0% sell. Price targets average $37.67, with the most cautious at $23.00 and the most optimistic at $57.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on SNDX.

Sign in to join the discussion.

Scroll to Top